Glaucoma: Types, Risk Factors, and Management

More than 3 million Americans live with glaucoma, yet roughly half of them don't know it (National Eye Institute). The disease earns its reputation as the "silent thief of sight" honestly — peripheral vision disappears so gradually that significant optic nerve damage can accumulate before anyone notices a problem. Globally, glaucoma is the leading cause of irreversible blindness, affecting an estimated 80 million people as of 2020 (World Health Organization).

Types of Glaucoma

Open-Angle Glaucoma

Open-angle glaucoma accounts for at least 90% of all glaucoma cases in the United States (National Eye Institute). The drainage angle formed by the cornea and iris remains physically open, but the trabecular meshwork — the spongy tissue near the angle responsible for fluid outflow — becomes less efficient over time. Aqueous humor drains too slowly, intraocular pressure (IOP) rises, and the optic nerve sustains progressive damage. The process unfolds over months to years, typically without pain or noticeable vision changes in its early stages.

Angle-Closure Glaucoma

Angle-closure glaucoma occurs when the iris bulges forward and physically blocks the drainage angle. This variant can present acutely — with sudden eye pain, headache, nausea, halos around lights, and a rapid spike in IOP — or chronically, with a slower narrowing over time. Acute angle-closure is an ophthalmic emergency; without prompt treatment, permanent vision loss can occur within hours. People of East Asian descent face a disproportionately higher risk of angle-closure disease compared to those of European descent (American Academy of Ophthalmology).

Normal-Tension Glaucoma

A particularly puzzling subtype: the optic nerve sustains glaucomatous damage even though IOP measures within the statistically "normal" range (typically 12–22 mmHg). Normal-tension glaucoma suggests that optic nerve vulnerability, vascular factors, or both play roles beyond pressure alone. It is more common among people of Japanese descent (National Eye Institute).

Secondary and Congenital Glaucoma

Secondary glaucoma develops as a consequence of another condition — trauma, inflammation, advanced cataracts, or prolonged corticosteroid use, among other triggers. Congenital glaucoma, present at birth, results from incomplete development of the eye's drainage system. It affects approximately 1 in 10,000 births in the United States (American Association for Pediatric Ophthalmology and Strabismus).

Risk Factors

Not all risk factors carry equal weight, and understanding which ones apply to a given individual helps guide screening frequency.

Age. Risk increases substantially after age 60. For African Americans, elevated risk begins closer to age 40 (National Eye Institute).
Race and ethnicity. African Americans are 6 to 8 times more likely to develop glaucoma than white Americans (Glaucoma Research Foundation). Hispanic and Latino populations also face increased risk, particularly after age 65.
Family history. Having a first-degree relative with glaucoma increases risk by an estimated 4 to 9 times (American Academy of Ophthalmology).
Elevated intraocular pressure. While not all people with elevated IOP develop glaucoma, higher pressure remains the strongest modifiable risk factor.
Corneal thickness. A central corneal thickness below 555 micrometers has been associated with greater glaucoma risk, as demonstrated by the Ocular Hypertension Treatment Study (National Eye Institute).
High myopia. Severely nearsighted eyes have structural features — elongated axial length, thinner sclera — that may predispose the optic nerve to damage.

Management Strategies

No treatment restores vision already lost to glaucoma. Every intervention aims at one target: lowering intraocular pressure enough to slow or halt further optic nerve damage.

Medications

Prostaglandin analogs (latanoprost, bimatoprost, travoprost) represent the most commonly prescribed first-line topical therapy. They work by increasing uveoscleral outflow and can lower IOP by 25–33%. Beta-blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors, and rho-kinase inhibitors offer additional or alternative pressure reduction (American Academy of Ophthalmology).

Laser Procedures

Selective laser trabeculoplasty (SLT) uses low-energy laser pulses to stimulate the trabecular meshwork. The LiGHT trial, published in The Lancet in 2019, demonstrated that initial SLT was at least as effective as eye drops for controlling IOP at 36 months and reduced the need for ongoing medication in 74.2% of participants (The Lancet, 2019). For angle-closure glaucoma, laser peripheral iridotomy — creating a small hole in the iris to improve fluid flow — remains a standard intervention.

Surgical Options

When medications and laser therapy prove insufficient, surgical approaches include trabeculectomy (creating a new drainage pathway), glaucoma drainage devices (tube shunts), and a growing category of minimally invasive glaucoma surgery (MIGS) procedures. MIGS techniques — such as the iStent, Kahook Dual Blade goniotomy, and Xen gel stent — offer lower complication profiles than traditional surgery, though they generally produce more modest IOP reductions.

Monitoring

Long-term management depends on consistent follow-up. Optical coherence tomography (OCT) measures retinal nerve fiber layer thickness with micrometer precision, detecting structural changes before they become visible on standard visual field testing. The combination of structural imaging and functional visual field analysis gives clinicians the clearest picture of disease stability or progression.

Frequently Asked Questions

How often should screening for glaucoma occur?

The American Academy of Ophthalmology recommends a baseline comprehensive eye exam at age 40 for all adults, with follow-up intervals determined by individual risk factors. Those over age 65, or those with elevated risk due to family history or race, benefit from examinations every 1 to 2 years (American Academy of Ophthalmology).

Can lifestyle changes reduce the risk of glaucoma progression?

Moderate aerobic exercise has been associated with modest IOP reduction — approximately 20% in some studies. Maintaining a healthy weight, avoiding excessive caffeine, and not smoking support overall ocular health, though no lifestyle modification substitutes for medical treatment once glaucoma is diagnosed.

Is glaucoma hereditary?

Genetic factors play a meaningful role, particularly in open-angle glaucoma. Specific gene variants — including MYOC, OPTN, and WDR36 — have been linked to glaucoma risk, though the disease is polygenic and influenced by environmental factors as well (National Human Genome Research Institute).

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)